FDA PATIENT REPRESENTATIVE PROGRAM Trademark

Trademark Overview


On Tuesday, January 30, 2018, a trademark application was filed for FDA PATIENT REPRESENTATIVE PROGRAM with the United States Patent and Trademark Office. The USPTO has given the FDA PATIENT REPRESENTATIVE PROGRAM trademark a serial number of 87776021. The federal status of this trademark filing is REGISTERED as of Tuesday, March 26, 2019. This trademark is owned by U.S. Department of Health and Human Services. The FDA PATIENT REPRESENTATIVE PROGRAM trademark is filed in the Advertising, Business and Retail Services and Education & Entertainment Services categories with the following description:

Training, including distributing course material in connection therewith, of patient advocates who will advise the U.S. Food and Drug Administration (FDA) on new and already approved medical products, drugs, biologics, and medical devices, and who provide advice to FDA early in the regulatory medical product development and review process

Recruitment of and promoting the retention of patient advocates who will advise the U.S. Food and Drug Administration (FDA) on new and already approved medical products, drugs, biologics, and medical devices, and who will provide advice to FDA early in the regulatory medical product development and review process
fda patient representative program

General Information


Serial Number87776021
Word MarkFDA PATIENT REPRESENTATIVE PROGRAM
Filing DateTuesday, January 30, 2018
Status700 - REGISTERED
Status DateTuesday, March 26, 2019
Registration Number5707463
Registration DateTuesday, March 26, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 8, 2019

Trademark Statements


Goods and ServicesTraining, including distributing course material in connection therewith, of patient advocates who will advise the U.S. Food and Drug Administration (FDA) on new and already approved medical products, drugs, biologics, and medical devices, and who provide advice to FDA early in the regulatory medical product development and review process
Goods and ServicesRecruitment of and promoting the retention of patient advocates who will advise the U.S. Food and Drug Administration (FDA) on new and already approved medical products, drugs, biologics, and medical devices, and who will provide advice to FDA early in the regulatory medical product development and review process
Disclaimer with Predetermined Text"PATIENT REPRESENTATIVE PROGRAM"

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, November 8, 2018
Primary Code035
First Use Anywhere DateSaturday, November 30, 1991
First Use In Commerce DateSaturday, November 30, 1991

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateFriday, February 9, 2018
Primary Code041
First Use Anywhere DateSaturday, November 30, 1991
First Use In Commerce DateSaturday, November 30, 1991

Trademark Owner History


Party NameU.S. Department of Health and Human Services
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBethesda, MD 20892

Party NameU.S. Department of Health and Human Services
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBethesda, MD 208922111

Party NameU.S. Department of Health and Human Services
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBethesda, MD 208922111

Trademark Events


Event DateEvent Description
Tuesday, March 26, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, January 4, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 4, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 4, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, January 4, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 4, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 4, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 26, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, January 8, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 8, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 19, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, November 10, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 8, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 7, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 7, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 25, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 25, 2018NON-FINAL ACTION E-MAILED
Friday, May 25, 2018NON-FINAL ACTION WRITTEN
Saturday, May 12, 2018ASSIGNED TO EXAMINER
Friday, February 9, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 2, 2018NEW APPLICATION ENTERED